| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,369 |
3,776 |
$143K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,141 |
1,060 |
$38K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
372 |
356 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
547 |
507 |
$25K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
191 |
177 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
653 |
637 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
313 |
151 |
$3K |
| 87428 |
|
62 |
62 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12 |
12 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
31 |
30 |
$1K |
| 98968 |
|
41 |
41 |
$962.52 |
| 90686 |
|
74 |
45 |
$320.00 |
| 90734 |
|
40 |
31 |
$160.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
13 |
12 |
$131.32 |
| 90619 |
|
40 |
40 |
$0.00 |
| 90715 |
|
20 |
14 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
82 |
56 |
$0.00 |